Medicamen Biotech Ltd
Medicamen Biotec | 531146
MEDICAMEQ - Share Price Chart
Stock Performance
Ratios
About Company
- A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets
- The Company has presence over 35+ countries
- Its offerings include Finished Dosage Forms (FDF's) to African countries
- In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market
- MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan)
- The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others
- The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce
- In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams
- Medicamen Biotech Limited was incorporated in December, 1993 and started their operation as distributor and manufacturer of medicines on loan license basis
- The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Medicamen Biotech Ltd?
The current share price of Medicamen Biotech Ltd (Medicamen Biotec) is ₹304.70. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Medicamen Biotech Ltd?
The Price-to-Earnings (P/E) ratio of Medicamen Biotech Ltd is 39.23. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a 52-week high of ₹447.65 and a 52-week low of ₹212.40. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Medicamen Biotech Ltd?
Medicamen Biotech Ltd offers a dividend yield of 0.32%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Medicamen Biotech Ltd?
The Earnings Per Share (EPS) of Medicamen Biotech Ltd is ₹7.98. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a Return on Equity (ROE) of 3.78%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
